CHINA PHARMA HOLDINGS, INC. Restricted Cash and Cash Equivalents, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Restricted Cash and Cash Equivalents, Current of $900.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Investments, Current › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue · last filed 2023-08-14
- 2023-06-30: Restricted Cash and Cash Equivalents, Current $900.00K.
- 2023-03-31: Restricted Cash and Cash Equivalents, Current $1.20M.
- 2022-12-31: Restricted Cash and Cash Equivalents, Current $2.00M.
- 2022-09-30: Restricted Cash and Cash Equivalents, Current $2.10M.
| Period end | Restricted Cash and Cash Equivalents, Current |
|---|---|
| 2023-06-30 | $900.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.20M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $2.00M 10-K · filed 2023-03-30 |
| 2022-09-30 | $2.10M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.20M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.70M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $4.90M 10-K · filed 2022-03-30 |
| 2021-09-30 | $500.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.80M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $500.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $960.00K 10-K · filed 2021-03-26 |
| 2020-09-30 | $350.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $1.80M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $100.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $1.10M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |